JustWire.io

Sun, 17.05.2026 Phreesia

US71944F1066

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Sat, 16.05.2026 Phreesia

US71944F1066

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities during the period of May 8, 2025 through March 30, 2026, inclusive (“the Class Period”). If you suffered a loss on your Phreesia investments, you have unti...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 15.05.2026 Phreesia

US71944F1066

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 15.05.2026 Phreesia

US71944F1066

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourage...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 15.05.2026 Phreesia

US71944F1066

SAN DIEGO, May 14, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026. Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 14.05.2026 Phreesia

US71944F1066

NEW YORK, May 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 14.05.2026 Phreesia

US71944F1066

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Phreesia To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Phreesia between May 8, 2025 and March 30, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 14.05.2026 Phreesia

US71944F1066

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026. Phreesia describes itself as a company that “provides an integrated SaaS-based software and payment platform for the healthcare industry in the United Stat...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 14.05.2026 Phreesia

US71944F1066

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026. Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.For more in...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 07.05.2026 Phreesia

US71944F1066

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 01.05.2026 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 01.05.2026 Phreesia

US71944F1066

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Sat, 18.04.2026 Phreesia

US71944F1066

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Phreesia, Inc. (NYSE: PHR) resulting from allegations that Phreesia may have issued materially misleading business information to the investing public. So What: If you purchased Phreesia securities you ma...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 16.04.2026 Phreesia

US71944F1066

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 15.04.2026 Phreesia

US71944F1066

Phreesia guided FY 2027 revenue at $545-$559 million while internal visibility into key segments was already deteriorating -- shareholders who lost money when the guidance was slashed to $510-$520 million may have legal rights. NEW YORK, April 15, 2026 /PRNewswire/ -- Phreesia (NYSE: PHR) shareholders lost between 29% of their investment in a sin...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 14.04.2026 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named to Becker’s Hospital Review’s 2026 list of “Revenue Cycle Management Companies to Know.” The annual list recognizes companies that play a critical role in helping healthcare organizations manage the growing complexity of revenue cycle operations, including patient access...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Mon, 13.04.2026 Phreesia

US71944F1066

New York, New York--(Newsfile Corp. - April 13, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential violations of the federal securities laws.On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 09.04.2026 Phreesia

US71944F1066

MediFind, a leading data-powered online provider directory, is proud to announce it received the DiMe Seal, developed by the Digital Medicine Society (DiMe), an independent nonprofit advancing the safe and effective use of digital health. MediFind is the first doctor directory to be awarded this seal. DiMe evaluates platforms based on core princ...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 08.04.2026 Phreesia

US71944F1066

New York, New York--(Newsfile Corp. - April 8, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE:PHR) concerning potential violations of the federal securities laws.On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 20...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 03.04.2026 Phreesia

US71944F1066

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose in...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 01.04.2026 Phreesia

US71944F1066

New York, New York--(Newsfile Corp. - April 1, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential violations of the federal securities laws.On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Mon, 30.03.2026 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2026. "We achieved several critical financial milestones ahead of our internal targets, including achieving positive GAAP net income ($2.3 million) and crossing $100 million of Adjusted EBITDA...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 24.03.2026 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named one of Becker’s Healthcare’s Top Places to Work in Healthcare for 2026. This marks Phreesia’s second time being included on the list, which recognizes hospitals, health systems and healthcare companies that invest in their people through strong benefits, professional dev...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Fri, 20.03.2026 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, and Sesame Workshop, the global nonprofit behind Sesame Street, received the Point of Care Excellence Award for their pediatric health and wellness campaign. The award, announced at the Point of Care Marketing Association’s (POCMA) POC Now Summit on March 18, recognizes outstanding c...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Mon, 16.03.2026 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") today announced the refinancing of its existing bridge loan (the “Bridge Loan”) by its entry into a new credit agreement providing for a senior secured revolving credit facility (the "New Credit Facility") of up to $275 million in aggregate principal amount, with Capital One, National Associ...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 12.03.2026 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Tiffany McGee, Assistant General Counsel, Commercial Contracts, has been named to The Software Report’s 2025 list of the Top Women Leaders in Software. Honorees were chosen based on their leadership and contributions to the software industry. This is the eig...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 10.03.2026 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named to the 2026 Capterra Shortlist for Appointment Scheduling. The Capterra Shortlist is an independent assessment that uses a proprietary blend of user ratings and popularity signals to identify leading products across software categories. Phreesia was named to four Capte...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 05.03.2026 Phreesia

US71944F1066

Phreesia today announced that Tara Sheehy, Senior Director of Client Experience for Phreesia Network Solutions, has been named to the MM+M Women to Watch class of 2026. Now in its 11th year, MM+M’s Women of Distinction and Women to Watch programs recognize healthcare marketing leaders who are making an impact on their companies and the industry....

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 03.03.2026 Phreesia

US71944F1066

Phreesia Network Solutions, a leader in healthcare media, is pleased to announce the launch of ProviderConnect, a first-of-its-kind offering for healthcare provider (HCP) marketers. Drawing on over two decades of experience of pioneering digital tools for direct-to-consumer health marketers, ProviderConnect enables life sciences brands and others...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Mon, 23.02.2026 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the “Company”) today announced that it has appointed Jon Kessler to its Board, effective April 6, 2026. In addition, Edward L. Cahill and Michael Weintraub have informed the Board that they will retire from the Board, effective at the 2026 Annual Meeting. Mr. Kessler is an experienced public company CEO...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 19.02.2026 Phreesia

US71944F1066

San Diego, California--(Newsfile Corp. - February 19, 2026) - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Phreesia, Inc. (NYSE: PHR). The investigation focuses on Phreesia's executive officers and whether investor losses may be recovered under federal securities laws.What if I purchased Phreesia securities?If yo...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 18.02.2026 Phreesia

US71944F1066

Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Phreesia, Inc. (NYSE: PHR). The investigation focuses on Phreesia’s executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Phreesia securities? If you purchased Phreesia securities and suffered losses on...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 17.02.2026 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter and fiscal year 2026 financial results after the close of market trading on Monday, March 30, 2026. Phreesia will issue a press release announcing its quarterly and full year results and the company’s quarterly stakeholder letter, both of which w...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 11.02.2026 Phreesia

US71944F1066

Phreesia is pleased to announce that Chaim Indig, CEO and co-founder of Phreesia, has been named to The Software Report’s Top 50 CEOs of 2025. This marks the third time Indig has received this recognition. The annual award honors leaders of high-performing software companies who have demonstrated success in delivering value to customers and lead...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 18.12.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named one of The Software Report’s “Top 50 Software Companies of 2025.” The annual awards program recognizes outstanding companies based on product excellence, organizational strength, company culture and growth, and management team caliber, among other attributes. This marks...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Mon, 08.12.2025 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2025. “I am very proud of our team’s strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories,” said CEO...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 04.12.2025 Phreesia

US71944F1066

Phreesia today announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M’s 2025 40 Under 40 list. MM+M’s annual 40 Under 40 list celebrates standout talent across healthcare marketing and communications. This year’s honorees were chosen for their impact in shaping the future of medical market...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 19.11.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Deloitte Technology Fast 500™. Now in its 31st year, the prestigious list ranks the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America. “We’re proud to be named to the Deloitte Fast 5...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Mon, 03.11.2025 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor web...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 08.10.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories. The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify a list of market leaders that offer the top products...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 16.09.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sara DiNardo, Vice President of Client Solutions, has been named in Becker’s Hospital Review’s 2025 list of Rising Stars: 100 Healthcare Leaders Under 40. "A new generation of bold, innovative healthcare leaders is making healthcare more accessible, affordab...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 04.09.2025 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. “I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net incom...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 04.09.2025 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia”), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries, “AccessOne”), a portfolio company of Frontier Growth, for aggregate consideration of $160 million in cash (the “AccessOne Acquisition...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 02.09.2025 Phreesia

US71944F1066

Phreesia, a leader in patient activation, today announced the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI leverages advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 21.08.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation that enables one in seven patient visits across the U.S., and Sesame Workshop, the global nonprofit behind Sesame Street, are pleased to announce a collaboration to educate and engage parents and caregivers of young children at the point of care. This press release features multimedia....

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 30.07.2025 Phreesia

US71944F1066

Patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life, according to new research from the COPD Foundation and Phreesia. C...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 09.07.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, has been named to Black Book Research’s 2025 list of Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management (RCM). The awards program is based on survey responses collected from 11,500+ healthcare finance professionals, administrators and RC...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Thu, 12.06.2025 Phreesia

US71944F1066

Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Kristin Roberts, Vice President of Product Management, has been named in Becker’s Hospital Review’s 2025 list of the 100 Women in Health IT to Know. “Women are leading the charge in transforming the future of healthcare through innovation in health IT,” Beck...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Wed, 28.05.2025 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025. "Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly livin...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Tue, 06.05.2025 Phreesia

US71944F1066

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of market trading on Wednesday, May 28, 2025. Phreesia previously announced that it would release the results after the close of market trading on the same day. Phreesia will issue a press release annou...

Phreesia

Technical Analysis Termsheets Terminal

Permalink

Newsfeed

PHR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026 | Phreesia, Inc.

INVESTOR ALERT: Securities Class Action Filed Against Phreesia, Inc. – Investors Encouraged to Contact Kirby McInerney LLP | Phreesia, Inc.

PHR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026 | Phreesia, Inc.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines - PHR | Phreesia, Inc.

PHR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Phreesia, Inc. | Phreesia, Inc.

PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit | Phreesia, Inc.

PHR INVESTOR NOTICE: Faruqi & Faruqi, LLP Notifies Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026 | Phreesia, Inc.

Rosen Law Firm Urges Phreesia, Inc. (NYSE: PHR) Stockholders to Contact the Firm for Information About Their Rights | Phreesia, Inc.

Investor Notice: Robbins LLP Informs Investors of the Phreesia, Inc. Class Action | Phreesia, Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Phreesia, Inc. - PHR | Phreesia, Inc.

Phreesia Sets Release Date for Fiscal First Quarter 2027 Results | Phreesia, Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Phreesia, Inc. - PHR | Phreesia, Inc.

Rosen Law Firm Encourages Phreesia, Inc. Investors to Inquire About Securities Class Action Investigation – PHR | Phreesia, Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Phreesia, Inc. - PHR | Phreesia, Inc.

PHR Investor Alert: Phreesia Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Allegedly Failing To Fully Disclose Weakening Revenue Visibility: Levi & Korsinsky | Phreesia, Inc.

Phreesia Named to Becker’s Hospital Review’s 2026 List of “Revenue Cycle Management Companies to Know” | Phreesia, Inc.

Investigation Underway: Phreesia, Inc. (PHR) - Contact Levi & Korsinsky Over Securities Law Violations | Phreesia, Inc.

MediFind Becomes First Doctor Directory to Receive the Digital Medicine Society Seal | Phreesia, Inc.

Protect Your Investment: Contact Levi & Korsinsky About the Phreesia, Inc. (PHR) Investigation | Phreesia, Inc.

PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm | Phreesia, Inc.

Investors in Phreesia, Inc. (PHR) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today | Phreesia, Inc.

Phreesia Announces Fourth Quarter Fiscal 2026 Results | Phreesia, Inc.

Phreesia Named One of Becker’s Top Places to Work in Healthcare | Phreesia, Inc.

Phreesia and Sesame Workshop Win Point of Care Excellence Award for Best Unbranded Campaign | Phreesia, Inc.

Phreesia Announces Refinancing of Bridge Loan with New $275 Million Revolving Credit Facility | Phreesia, Inc.

Phreesia’s Tiffany McGee Named a Top Woman Leader in Software | Phreesia, Inc.

Phreesia Named to the 2026 Capterra Shortlist for Appointment Scheduling | Phreesia, Inc.

Phreesia’s Tara Sheehy Named to MM+M Women to Watch | Phreesia, Inc.

Phreesia Network Solutions Launches ProviderConnect, a Pioneering Offering to Engage Clinicians When It Matters Most | Phreesia, Inc.

Phreesia Appoints Jon Kessler to Board of Directors | Phreesia, Inc.

Phreesia Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses | Phreesia, Inc.

Phreesia Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses | Phreesia, Inc.

Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2026 Results | Phreesia, Inc.

Phreesia CEO Chaim Indig Named to The Software Report’s Top 50 CEOs of 2025 | Phreesia, Inc.

Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year | Phreesia, Inc.

Phreesia Announces Third Quarter Fiscal 2026 Results and Introduces Fiscal 2027 Outlook | Phreesia, Inc.

Phreesia’s Megan Turco Named to MM+M 40 Under 40 | Phreesia, Inc.

Phreesia Named to the 2025 Deloitte Technology Fast 500™ | Phreesia, Inc.

Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results | Phreesia, Inc.

Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling | Phreesia, Inc.

Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare | Phreesia, Inc.

Phreesia Announces Second Quarter Fiscal 2026 Results | Phreesia, Inc.

Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions | Phreesia, Inc.

Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare | Phreesia, Inc.

Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street | Phreesia, Inc.

New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication | Phreesia, Inc.

Phreesia Named in Black Book Research’s List of 2025’s Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management | Phreesia, Inc.

Becker’s Names Phreesia’s Kristin Roberts as one of 2025’s 100 Women in Health IT to Know | Phreesia, Inc.

Phreesia Announces First Quarter Fiscal 2026 Results | Phreesia, Inc.

Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results | Phreesia, Inc.